Westlake Corporation Reports Third Quarter 2024 Results

In This Article:

HOUSTON, November 05, 2024--(BUSINESS WIRE)--Westlake Corporation (NYSE: WLK) (the "Company" or "Westlake") today announced third quarter 2024 results.

SUMMARY FINANCIAL HIGHLIGHTS (in millions of dollars, except per share data and percentages)

 

 

Three Months
Ended
September 30, 2024

 

Three Months
Ended June 30,
2024

 

Three Months
Ended
September 30,
2023

 

 

 

 

 

 

 

Westlake Corporation

 

 

 

 

 

 

Net sales

 

$

3,117

 

 

$

3,207

 

 

$

3,115

 

Income from operations

 

$

180

 

 

$

406

 

 

$

349

 

Net income attributable to Westlake Corporation

 

$

108

 

 

$

313

 

 

$

285

 

Diluted earnings per common share

 

$

0.83

 

 

$

2.40

 

 

$

2.20

 

Identified Item (1)

 

$

75

 

 

$

 

 

$

 

Net income attributable to Westlake Corporation excl. Identified Item

 

$

183

 

 

$

313

 

 

$

285

 

Diluted earnings per common share excl. Identified Item

 

$

1.41

 

 

$

2.40

 

 

$

2.20

 

EBITDA

 

$

505

 

 

$

744

 

 

$

682

 

EBITDA excl. Identified Item

 

$

580

 

 

$

744

 

 

$

682

 

EBITDA margin (2)

 

 

19%

 

 

23%

 

 

22%

 

 

 

 

 

 

 

Performance and Essential Materials ("PEM") Segment

 

 

 

 

 

 

Net sales

 

$

2,019

 

 

$

2,013

 

 

$

1,971

 

Income from operations

 

$

(9

)

 

$

157

 

 

$

105

 

EBITDA

 

$

222

 

 

$

391

 

 

$

339

 

Identified Item (1)

 

$

75

 

 

$

 

 

$

 

EBITDA excl. Identified Item

 

$

297

 

 

$

391

 

 

$

339

 

EBITDA margin (2)

 

 

15%

 

 

19%

 

 

17%

 

 

 

 

 

 

 

Housing and Infrastructure Products ("HIP") Segment

 

 

 

 

 

 

Net sales

 

$

1,098

 

 

$

1,194

 

 

$

1,144

 

Income from operations

 

$

202

 

 

$

266

 

 

$

256

 

EBITDA

 

$

262

 

 

$

336

 

 

$

327

 

EBITDA margin

 

 

24%

 

 

28%

 

 

29%

______________________________

(1)

"Identified Item" represents $75 million accrued expense to temporarily cease operations ("mothball") of the allyl chloride (AC) and epichlorohydrin (ECH) units at the Company's site in Pernis, the Netherlands

(2)

Excludes Identified Item

RESULTS

Consolidated Results

(Unless otherwise noted the financial numbers below exclude the Identified Item)